Today: 7 February 2026
Subscribe
Browse Category

Financial Forecasts News 7 January 2026 - 6 February 2026

Bloom Energy stock whipsaws after big 2026 forecast — what traders watch next

Bloom Energy stock whipsaws after big 2026 forecast — what traders watch next

Bloom Energy shares reversed a 15.9% early surge Friday, falling 0.7% to $135.64 after the company set a 2026 revenue forecast of $3.1–$3.3 billion and reported a $6 billion backlog. Volume hit 15 million shares. Bloom posted Q4 revenue of $777.7 million and full-year revenue of $2.02 billion. The company announced a partnership with Oracle and a $5 billion AI infrastructure alliance with Brookfield.
6 February 2026
···
Eli Lilly stock price jumps 10% after-hours on upbeat 2026 forecast and Q4 beat

Eli Lilly stock price jumps 10% after-hours on upbeat 2026 forecast and Q4 beat

Eli Lilly shares jumped 10.4% to $1,107.12 in after-hours trading Wednesday after reporting fourth-quarter revenue up 43% to $19.29 billion and a 2026 profit outlook above Wall Street forecasts. The company expects 2026 revenue of $80–83 billion and non-GAAP earnings per share of $33.50–$35.00. Mounjaro sales reached $7.41 billion and Zepbound $4.26 billion for the quarter.
4 February 2026
··
SanDisk stock jumps as AI memory shortage fuels a bold Q3 forecast

SanDisk stock jumps as AI memory shortage fuels a bold Q3 forecast

SanDisk forecast third-quarter revenue of $4.4–$4.8 billion and non-GAAP EPS of $12–$14, sending shares up over 9% after hours. The company posted $3.025 billion revenue and $803 million net profit for Q2, reversing a prior loss. SanDisk extended its Kioxia joint venture to 2034 and committed $1.165 billion to manufacturing services. Memory chip prices are surging amid an “unprecedented” shortage, driven by AI data center demand.
3 February 2026
····
DaVita stock jumps after hours on upbeat 2026 profit forecast and earnings beat

DaVita stock jumps after hours on upbeat 2026 profit forecast and earnings beat

DaVita shares rose 11.7% to $124.17 in after-hours trading after posting quarterly earnings and a 2026 profit forecast above analyst estimates. The company reported fourth-quarter adjusted profit of $3.40 per share on $3.62 billion in revenue. DaVita projected 2026 adjusted earnings of $13.60 to $15.00 per share, topping the $12.65 consensus. Investors await details on reimbursement, costs, and patient volumes.
2 February 2026
···
Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
30 January 2026
···
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares closed at $523.99 Friday, down 0.4% after the company forecast da Vinci procedure growth of 13%–15% by 2026 and warned tariffs could pressure margins. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted earnings of $2.53 per share. The company reported over 20 million da Vinci procedures worldwide. FDA cleared new cardiac uses for its da Vinci 5 robot.
25 January 2026
··
GSK share price in focus after China clears Trelegy for asthma — what to watch next week

GSK share price in focus after China clears Trelegy for asthma — what to watch next week

GSK shares closed down 0.2% at 1,801 pence in London Friday after China approved Trelegy Ellipta for uncontrolled asthma in adults. The expanded label gives GSK access to an estimated 46 million adults with asthma in China. Investors await GSK’s Q4 and full-year results, set for Feb. 4. The FTSE 100 slipped 0.07% on the day.
24 January 2026
·····
Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Morgan Stanley Upgrade Lifts MDA Space as 2026 Space-Tech Funding Forecast Rises

Private investment in space technology jumped 48% to $12.4 billion in 2025, Seraphim Space said, with further gains expected in 2026. MDA Space shares surged 14.5% after a Morgan Stanley upgrade, while Rocket Lab’s price target was raised to $105. Canadian stocks slipped 0.1% after U.S. tariff threats. MDA recently secured a U.S. Missile Defense Agency contract for its SHIELD program.
19 January 2026
····
SoFi stock price forecast: BofA’s $20.50 target clashes with Barclays’ $28 as earnings loom

SoFi stock price forecast: BofA’s $20.50 target clashes with Barclays’ $28 as earnings loom

New York, Jan 7, 2026, 15:46 ET — Regular session SoFi Technologies shares were down about 0.1% at $26.96 on Wednesday afternoon, with roughly 37.5 million shares traded. The stock ended Tuesday at $26.98, down 7.9% from Monday’s $29.28 close. Nasdaq The slide has put the SoFi stock price forecast back under a harsh light, with investors weighing dilution from the company’s latest equity raise against the case for faster growth into 2026. Earnings later this month are the next hard checkpoint, and the tape is telling traders to keep their seatbelts on. In a filing, SoFi said underwriters exercised
7 January 2026
··
Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

NEW YORK, January 7, 2026, 15:31 EST — Regular session Oracle shares were little changed on Wednesday as investors digested fresh analyst calls that painted a wide 12-month path for the stock. The shares were down 0.1% at $193.52 in mid-afternoon trade, after touching $195.49 earlier in the session. Why it matters now: Oracle has become a proxy for investor nerves around debt-funded AI data-center buildouts and customer concentration. UBS analyst Karl Keirstead cut his price target to $280 from $325 on Monday while keeping a “Buy” rating, saying the roughly 41% slide from mid-September highs showed confidence has cracked
7 January 2026
·
1 2 3 … 68

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop